The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Cardiome Pharma Corp

TSX: COM
Delayed quote

$9.47

Today's change+0.35 +3.84%
Updated November 27 9:30 AM EST. Delayed by at least 15 minutes.
 

Cardiome Pharma Corp

TSX: COM
Delayed quote

$9.47

Today's change+0.35 +3.84%
Updated November 27 9:30 AM EST. Delayed by at least 15 minutes.

Cardiome Pharma Corp crosses above 50-day moving average

Cardiome Pharma Corp closed up sharply Thursday, rallying $0.35 or 3.84% to $9.47 and crossing above its 50-day moving average. Over the last five days, shares have gained 4.41% and 41.34% year to date. Shares have outperformed the S&P TSX by 33.53% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$1.41
Updated November 27 9:30 AM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-70.45%

Cardiome Pharma Corp has a net profit margin of -70.45%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX1.13%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue8884
Total other revenue--------
Total revenue8884
Gross profit5563
Total cost of revenue3211
Total operating expense11121011
Selling / general / administrative8987
Research & development0000
Depreciation / amortization1110
Interest expense (income), net operating--------
Unusual expense (income)0003
Other operating expenses, total--------
Operating income-3-4-3-8
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-4-4-3-7
Income after tax-4-4-3-7
Income tax, total0000
Net income-4-4-3-7
Total adjustments to net income--------
Net income before extra. items-4-4-3-7
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-4-4-3-7
Inc. avail. to common incl. extra. items-4-4-3-7
Diluted net income-4-4-3-7
Dilution adjustment----00
Diluted weighted average shares17171514
Diluted EPS excluding extraordinary itemsvalue per share-0.26-0.26-0.20-0.53
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.26-0.26-0.20-0.39